Period of time: 2014年3期
Publisher: Informa Healthcare
Founded in: 2006
Total resources: 77
ISSN: 1746-0441
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Discovery,volume 5,issue 3
Menu
Pharmacophore-based virtual screening: a review of recent applications
By Kim Kyun-Hwan,Kim Nam Doo,Seong Baik-Lin in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 3 , Vol. 5, Iss. 3, 2010-03 , pp.Cell viability assessment: toward content-rich platforms
By Ramirez Christina Nicole,Antczak Christophe,Djaballah Hakim in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 3 , Vol. 5, Iss. 3, 2010-03 , pp.Lipophilicity in drug discovery
Expert Opinion on Drug Discovery,volume 5,issue 3 , Vol. 5, Iss. 3, 2010-03 , pp.Practical metabolomics in drug discovery
By Wilcoxen Keith M,Uehara Taisuke,Myint Khin Than,Sato Yoshiaki,Oda Yoshiya in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 3 , Vol. 5, Iss. 3, 2010-03 , pp.Parathyroid gland regulation: contribution of the
By Carrillo-López Natalia,Román-García Pablo,Fernández-Martín José L,Cannata-Andía Jorge B in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 3 , Vol. 5, Iss. 3, 2010-03 , pp.Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors
By Eglen Richard M,Reisine Terry in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 3 , Vol. 5, Iss. 3, 2010-03 , pp.The role and future potential of fluorinated biomarkers in positron emission tomography
By Daniels Stephen,Tohid Siti Farah Md,Velanguparackel Winnie,Westwell Andrew D in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 3 , Vol. 5, Iss. 3, 2010-03 , pp.